Health
SARS-CoV-2 evolves antibody resistance in immunocompromised patient – News-Medical.Net
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found…
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
The SARS-CoV-2 virus is the agent responsible for the coronavirus 2019 (COVID-19) pandemic that continues to pose a significant threat to global public health and the worldwide economy.
The team’s analysis…
-
Noosa News10 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General11 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Business13 hours agoTime to buy before it’s too late?
-
General19 hours agoFormer Marine Paul Doyle pleads guilty to Liverpool FC parade car ramming charges